A narrative review on advances in neoadjuvant immunotherapy for esophageal cancer: Molecular biomarkers and future directions

2024-9-14

Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating <scp>DNA</scp> damage repair pathways

2024-9-9

<scp>FHL2</scp> expression by cancer‐associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma

2024-9-8

Identification and evaluation of a serum <scp>microRNA</scp> panel to diagnose colorectal cancer patients

2024-9-8

Uncovering possible silent acquired long <scp>QT</scp> syndrome using exercise stress testing in long‐term pediatric acute lymphoblastic leukemia survivors

2024-9-8

Impact of organized and opportunistic screening on excess mortality and on social inequalities in breast cancer survival

2024-9-7

Breast cancer survival analysis in the Republic of Mauritius by age, stage at diagnosis and molecular subtype: A retrospective cohort study

2024-9-7

Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de‐differentiation (ARON‐1 study)

2024-9-7

Enhanced pharmacological activities of AKR1C3‐activated prodrug AST‐3424 in cancer cells with defective DNA repair

2024-9-7

Aflatoxin exposure is associated with an increased risk of gallbladder cancer

2024-9-6

14‐3‐3σ restricts <scp>YY1</scp> to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer

2024-9-6

Comments on “<scp>Epidemiological</scp> trends and survival of oropharyngeal cancer in a high <scp>HPV</scp>‐prevalent area: <scp>A Danish</scp> population‐based study from 2000 to 2020”

2024-9-6

Combined inhibition of RAD51 and CHK1 causes synergistic toxicity in cisplatin resistant cancer cells by triggering replication fork collapse

2024-9-6

Response to: Comments on “Epidemiological trends and survival of oropharyngeal cancer in a high <scp>HPV</scp>‐prevalent area: A Danish population‐based study from 2000 to 2020”

2024-9-6

Issue Information

2024-9-5

Tumor deposits should not be placed in the <scp>M</scp> category of <scp>TNM</scp>: <scp>A</scp> comparative survival analysis using <scp>SEER</scp> data

2024-9-5

Impact of accelerated biological aging and genetic variation on esophageal adenocarcinoma: Joint and interaction effect in a prospective cohort

2024-9-4

The Man Van: A pilot study of using mobile targeted case‐finding to address health inequalities in prostate cancer

2024-9-4

Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival—A prospective cohort study in Australia

2024-9-2

Occupational exposure to benzene and risk of non‐<scp>Hodgkin</scp> lymphoma in an extended follow‐up of two population‐based prospective cohorts of <scp>Chinese</scp> men and women

2024-9-2

Aneuploidy in neoplasia: <scp>Single</scp>‐cell data on 83,862 tumors

2024-9-2

Humoral immune response as an indicator for protection against Covid‐19 after anti‐SARS‐COV2‐booster vaccination in hematological and oncological patients

2024-9-2

World Cancer Congress IJC abstract supplementPreface

2024-9-1

Issue Information

2024-9-1

Abstracts

2024-9-1

Author Index

2024-9-1

Association between immune checkpoint inhibitor and cytomegalovirus infection: A pharmacovigilance study based on the adverse event reporting system

2024-8-31

Early circulating tumor <scp>DNA</scp> changes predict outcomes in head and neck cancer patients under re‐radiotherapy

2024-8-30

Mutational signatures and their association with cancer survival and gene expression in multiple cancer types

2024-8-28

Survivorship program including long‐term toxicities and quality‐of‐life development over 10 years in a randomized trial in operable stage III non‐small‐cell lung cancer (<scp>ESPATUE</scp>)

2024-8-28

<scp>Expression of Concern</scp>: A small molecule, <scp>LLL12</scp> inhibits constitutive <scp>STAT3</scp> and <scp>IL</scp>‐6‐induced <scp>STAT3</scp> signaling and exhibits potent growth suppressive activity in human multiple myeloma cells

2024-8-28

<scp>RETRACTION</scp>: High‐density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells

2024-8-28

The transcriptional landscape and clinico‐biological characterization of human endogenous retroviruses in esophageal squamous cell carcinoma

2024-8-27

Comments on “<scp>Differences</scp> in survival and recurrence of colorectal cancer by stage across population‐based <scp>European</scp> registries”

2024-8-27

Optimal therapeutic strategies for hepatic metachronous oligometastatic nasopharyngeal carcinoma: Insights from a retrospective study

2024-8-26

Tripokin: <scp>A</scp> multi‐specific immunocytokine for cancer immunotherapy

2024-8-23

Adherence to melanoma screening and surveillance skin check schedules tailored to personal risk

2024-8-23

Optimizing treatment sequence for inoperable locally advanced breast cancer: Long‐term outcomes of surgery first versus neoadjuvant chemotherapy in a real‐world setting

2024-8-23

Does ambient particulate matter 1 increase the risk of gastric cancer in the northwest of <scp>China</scp>?

2024-8-23

Recurrent cervical cancer detection using DNA methylation markers in self‐collected samples from home

2024-8-22

Prolonged inhibition of intratumoral mast cells enhances efficacy of low‐dose antiangiogenic therapy

2024-8-22

B cells critical for outcome in high grade serous ovarian carcinoma

2024-8-22

Representation of women in clinical trials supporting <scp>FDA</scp>‐approval of contemporary cancer therapies

2024-8-19

Cholecystectomy and digestive cancer in Chile: Complementary results from interrupted time series and aggregated data analyses

2024-8-16